Zoi Alexiou

1.4k total citations
7 papers, 98 citations indexed

About

Zoi Alexiou is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Zoi Alexiou has authored 7 papers receiving a total of 98 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Infectious Diseases and 2 papers in Surgery. Recurrent topics in Zoi Alexiou's work include Sepsis Diagnosis and Treatment (3 papers), Urinary Tract Infections Management (1 paper) and Inflammation biomarkers and pathways (1 paper). Zoi Alexiou is often cited by papers focused on Sepsis Diagnosis and Treatment (3 papers), Urinary Tract Infections Management (1 paper) and Inflammation biomarkers and pathways (1 paper). Zoi Alexiou collaborates with scholars based in Greece, United States and United Kingdom. Zoi Alexiou's co-authors include Nicholas Katsilambros, Panagiotis Tsapogas, Marios Arvanitis, Nicholas A. Tritos, Evangelos J. Giamarellos‐Bourboulis, Petros Kopterides, Stylianos E. Orfanos, Ioannis Koutelidakis, Maria Mouktaroudi and Theologia Gkavogianni and has published in prestigious journals such as International Journal of Molecular Sciences, Diabetic Medicine and International Journal of Antimicrobial Agents.

In The Last Decade

Zoi Alexiou

7 papers receiving 91 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zoi Alexiou Greece	5	46	31	22	21	17	7	98
Benjamin Delwarde France	8	36 0.8×	49 1.6×	16 0.7×	8 0.4×	49 2.9×	12	125
Takahiro Okutani Japan	7	49 1.1×	21 0.7×	45 2.0×	23 1.1×	3 0.2×	15	122
Adarsh Katamreddy United States	7	41 0.9×	33 1.1×	18 0.8×	9 0.4×	4 0.2×	19	104
John C. Lin United States	5	12 0.3×	54 1.7×	21 1.0×	6 0.3×	15 0.9×	9	88
Aikaterini Ioakeimidou Greece	4	11 0.2×	67 2.2×	29 1.3×	41 2.0×	23 1.4×	4	95
Abdul Malik Sheikh Pakistan	6	43 0.9×	30 1.0×	23 1.0×	13 0.6×	3 0.2×	18	124
Rombout B. E. van Amstel Netherlands	6	15 0.3×	41 1.3×	22 1.0×	13 0.6×	14 0.8×	13	117
Machi Yanai Japan	7	15 0.3×	8 0.3×	18 0.8×	5 0.2×	9 0.5×	9	83
Jean-Baptiste Roudaut France	4	13 0.3×	37 1.2×	60 2.7×	38 1.8×	3 0.2×	8	118
Ramón Cicuéndez Spain	2	13 0.3×	69 2.2×	14 0.6×	4 0.2×	14 0.8×	4	92

Countries citing papers authored by Zoi Alexiou

Since Specialization

Citations

This map shows the geographic impact of Zoi Alexiou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoi Alexiou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoi Alexiou more than expected).

Fields of papers citing papers by Zoi Alexiou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zoi Alexiou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoi Alexiou. The network helps show where Zoi Alexiou may publish in the future.

Co-authorship network of co-authors of Zoi Alexiou

This figure shows the co-authorship network connecting the top 25 collaborators of Zoi Alexiou. A scholar is included among the top collaborators of Zoi Alexiou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoi Alexiou. Zoi Alexiou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Kyriazopoulou, Evdoxia, Georgia Damoraki, Panagiotis Koufargyris, et al.. (2025). Procalcitonin-guided early cessation of antibiotics prevents gut inflammation and preserves gut microbiome: Data from the PROGRESS controlled trial. International Journal of Antimicrobial Agents. 66(2). 107507–107507. 1 indexed citations

Kyriazopoulou, Evdoxia, George Ν. Dalekos, Symeon Metallidis, et al.. (2024). HEPARIN-BINDING PROTEIN LEVELS PREDICT UNFAVORABLE OUTCOME IN COVID-19 PNEUMONIA: A POST HOC ANALYSIS OF THE SAVE TRIAL. Shock. 61(3). 395–399. 2 indexed citations

Poulakou, Garyphalia, George Adamis, Aggeliki Rapti, et al.. (2022). Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19. International Journal of Molecular Sciences. 23(9). 4894–4894. 18 indexed citations

Kotsaki, Antigone, Nikolaos Tziolos, Ioannis Koutelidakis, et al.. (2022). Oral minocycline plus rifampicin versus oral linezolid for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: the AIDA open label, randomized, controlled Phase 4 trial. EClinicalMedicine. 56. 101790–101790. 4 indexed citations

Spyridaki, Aikaterini, Petros Kopterides, Aikaterini Pistiki, et al.. (2011). TREM-1 expression on neutrophils and monocytes of septic patients: relation to the underlying infection and the implicated pathogen. BMC Infectious Diseases. 11(1). 309–309. 14 indexed citations

Alexiou, Zoi, Maria Mouktaroudi, George Koratzanis, et al.. (2007). The significance of compliance for the success of antimicrobial prophylaxis in recurrent lower urinary tract infections: the Greek experience. International Journal of Antimicrobial Agents. 30(1). 40–43. 11 indexed citations

Katsilambros, Nicholas, et al.. (1996). Risk Factors for Lower Extremity Arterial Disease in Non-insulin-dependent Diabetic Persons. Diabetic Medicine. 13(3). 243–246. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact